메뉴 건너뛰기




Volumn 25, Issue 4, 2009, Pages 733-751

Optimizing Antimicrobial Therapy in Sepsis and Septic Shock

Author keywords

Antibiotic; Life threatening infections; Pharmacodynamics; Pharmacokinetics; Sepsis; Septic shock; Therapy

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; ERYTHROMYCIN; HYDRAZIDE; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; MEZLOCILLIN; MOXIFLOXACIN; NAFCILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE; TICARCILLIN; UNINDEXED DRUG; VANCOMYCIN;

EID: 70350594710     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.08.004     Document Type: Review
Times cited : (61)

References (96)
  • 1
    • 0034958947 scopus 로고    scopus 로고
    • Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
    • Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
    • (2001) Crit Care Med , vol.29 , pp. 1303-1310
    • Angus, D.C.1    Linde-Zwirble, W.T.2    Lidicker, J.3
  • 2
    • 10344258702 scopus 로고
    • Occurrence of serious bacterial infections since the introduction of antibacterial agents
    • Finland M., Jones W.F., and Barnes M.W. Occurrence of serious bacterial infections since the introduction of antibacterial agents. JAMA 84 (1959) 2188-2197
    • (1959) JAMA , vol.84 , pp. 2188-2197
    • Finland, M.1    Jones, W.F.2    Barnes, M.W.3
  • 3
    • 0017029952 scopus 로고
    • Effect of antibiotics on mortality from infectious diseases in Sweden and Finland
    • Hemminki E., and Paakkulainen A. Effect of antibiotics on mortality from infectious diseases in Sweden and Finland. Am J Public Health 66 (1976) 1180-1184
    • (1976) Am J Public Health , vol.66 , pp. 1180-1184
    • Hemminki, E.1    Paakkulainen, A.2
  • 4
    • 0018834461 scopus 로고
    • Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients
    • Kreger B.E., Craven D.E., and McCabe W.R. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68 (1980) 344-355
    • (1980) Am J Med , vol.68 , pp. 344-355
    • Kreger, B.E.1    Craven, D.E.2    McCabe, W.R.3
  • 5
    • 0037451929 scopus 로고    scopus 로고
    • The epidemiology of sepsis in the United States from 1979 through 2000
    • Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
    • (2003) N Engl J Med , vol.348 , pp. 1546-1554
    • Martin, G.S.1    Mannino, D.M.2    Eaton, S.3
  • 7
    • 0032433470 scopus 로고    scopus 로고
    • Has the mortality of septic shock changed with time
    • Friedman G., Silva E., and Vincent J.L. Has the mortality of septic shock changed with time. Crit Care Med 26 (1998) 2078-2086
    • (1998) Crit Care Med , vol.26 , pp. 2078-2086
    • Friedman, G.1    Silva, E.2    Vincent, J.L.3
  • 8
    • 33744527833 scopus 로고    scopus 로고
    • Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
    • Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006) 1589-1596
    • (2006) Crit Care Med , vol.34 , pp. 1589-1596
    • Kumar, A.1    Roberts, D.2    Wood, K.E.3
  • 9
    • 0031472414 scopus 로고    scopus 로고
    • Quality of care, process, and outcomes in elderly patients with pneumonia
    • Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 (1997) 2080-2084
    • (1997) JAMA , vol.278 , pp. 2080-2084
    • Meehan, T.P.1    Fine, M.J.2    Krumholz, H.M.3
  • 10
    • 0141610906 scopus 로고    scopus 로고
    • The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
    • Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
    • (2000) Chest , vol.118 , pp. 146-155
    • Ibrahim, E.H.1    Sherman, G.2    Ward, S.3
  • 11
    • 0032911760 scopus 로고    scopus 로고
    • Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
    • Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
    • (1999) Chest , vol.115 , pp. 462-474
    • Kollef, M.H.1    Sherman, G.2    Ward, S.3
  • 12
    • 0034457796 scopus 로고    scopus 로고
    • Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients
    • Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31 Suppl 4 (2000) S131-S138
    • (2000) Clin Infect Dis , vol.31 , Issue.SUPPL. 4
    • Kollef, M.H.1
  • 13
    • 2142760947 scopus 로고    scopus 로고
    • Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
    • Drusano G.L. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2 (2004) 289-300
    • (2004) Nat Rev Microbiol , vol.2 , pp. 289-300
    • Drusano, G.L.1
  • 14
    • 0036229241 scopus 로고    scopus 로고
    • Pharmacological principles of antibiotic prescription in the critically ill
    • Pinder M., Bellomo R., Lipman J., et al. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 30 (2002) 134-144
    • (2002) Anaesth Intensive Care , vol.30 , pp. 134-144
    • Pinder, M.1    Bellomo, R.2    Lipman, J.3
  • 15
    • 0033984889 scopus 로고    scopus 로고
    • New pharmacodynamic parameters for antimicrobial agents
    • Li R.C. New pharmacodynamic parameters for antimicrobial agents. Int J Antimicrob Agents 13 (2000) 229-235
    • (2000) Int J Antimicrob Agents , vol.13 , pp. 229-235
    • Li, R.C.1
  • 16
    • 0028275580 scopus 로고
    • Principles of antibiotic therapy
    • Solomkin J.S., and Miyagawa C.I. Principles of antibiotic therapy. Surg Clin North Am 74 3 (1994) 497-517
    • (1994) Surg Clin North Am , vol.74 , Issue.3 , pp. 497-517
    • Solomkin, J.S.1    Miyagawa, C.I.2
  • 17
    • 0031952586 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
    • Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26 (1998) 1-10
    • (1998) Clin Infect Dis , vol.26 , pp. 1-10
    • Craig, W.A.1
  • 18
    • 0023614450 scopus 로고
    • Inadequacy of standard aminoglycoside loading doses in acutely ill patients
    • Chelluri L., and Jastremski M.S. Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Crit Care Med 15 (1987) 1143-1145
    • (1987) Crit Care Med , vol.15 , pp. 1143-1145
    • Chelluri, L.1    Jastremski, M.S.2
  • 19
    • 0242266613 scopus 로고    scopus 로고
    • Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    • Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115 (2003) 529-535
    • (2003) Am J Med , vol.115 , pp. 529-535
    • Harbarth, S.1    Garbino, J.2    Pugin, J.3
  • 20
    • 0019977180 scopus 로고
    • Anti-anaerobic antibacterial agents
    • Bartlett J.G. Anti-anaerobic antibacterial agents. Lancet 2 8296 (1982) 478-481
    • (1982) Lancet , vol.2 , Issue.8296 , pp. 478-481
    • Bartlett, J.G.1
  • 21
    • 0017162278 scopus 로고
    • Therapy of neutropenic rats infected with pseudomonas aeruginosa
    • Lumish R.M., and Norden C.W. Therapy of neutropenic rats infected with pseudomonas aeruginosa. J Infect Dis 133 (1976) 538-547
    • (1976) J Infect Dis , vol.133 , pp. 538-547
    • Lumish, R.M.1    Norden, C.W.2
  • 22
    • 0035522333 scopus 로고    scopus 로고
    • Infective endocarditis in adults
    • Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 18 (2001) 1318-1330
    • (2001) N Engl J Med , vol.345 , Issue.18 , pp. 1318-1330
    • Mylonakis, E.1    Calderwood, S.B.2
  • 23
    • 77049168380 scopus 로고
    • Antibiotic therapy of bacterial endocarditis: VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases
    • Geraci J.E., and Martin W.J. Antibiotic therapy of bacterial endocarditis: VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10 (1954) 173-194
    • (1954) Circulation , vol.10 , pp. 173-194
    • Geraci, J.E.1    Martin, W.J.2
  • 24
    • 0347948546 scopus 로고    scopus 로고
    • Infective endocarditis
    • Moreillon P., and Que Y.A. Infective endocarditis. Lancet 363 9403 (2004) 139-149
    • (2004) Lancet , vol.363 , Issue.9403 , pp. 139-149
    • Moreillon, P.1    Que, Y.A.2
  • 25
    • 0020107992 scopus 로고
    • Synergistic combinations of antibiotics in gram-negative bacillary infections
    • Klastersky J., and Zinner S.H. Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis 4 (1982) 294-301
    • (1982) Rev Infect Dis , vol.4 , pp. 294-301
    • Klastersky, J.1    Zinner, S.H.2
  • 26
    • 0037563090 scopus 로고    scopus 로고
    • Beta-lactam monotherapy versus b-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis
    • Paul M., Soares-Weiser K., and Leibovici L. Beta-lactam monotherapy versus b-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. Br Med J 326 (2003) 1111-1118
    • (2003) Br Med J , vol.326 , pp. 1111-1118
    • Paul, M.1    Soares-Weiser, K.2    Leibovici, L.3
  • 27
    • 4043059435 scopus 로고    scopus 로고
    • Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis
    • Safdar N., Handelsman J., Maki D.G., et al. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4 (2004) 519-527
    • (2004) Lancet Infect Dis , vol.4 , pp. 519-527
    • Safdar, N.1    Handelsman, J.2    Maki, D.G.3
  • 28
    • 34447126309 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of antimicrobials
    • Drusano G.L. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin Infect Dis 45 Suppl 1 (2007) S89-95
    • (2007) Clin Infect Dis , vol.45 , Issue.SUPPL. 1
    • Drusano, G.L.1
  • 29
    • 62849095029 scopus 로고    scopus 로고
    • Pharmacokinetic issues for antibiotics in the critically ill patient
    • quiz 859
    • Roberts J.A., and Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37 3 (2009) 840-851 quiz 859
    • (2009) Crit Care Med , vol.37 , Issue.3 , pp. 840-851
    • Roberts, J.A.1    Lipman, J.2
  • 30
    • 50349092141 scopus 로고    scopus 로고
    • Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
    • Roberts J.A., Lipman J., Blot S., et al. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care 14 4 (2008) 390-396
    • (2008) Curr Opin Crit Care , vol.14 , Issue.4 , pp. 390-396
    • Roberts, J.A.1    Lipman, J.2    Blot, S.3
  • 31
    • 33748103189 scopus 로고    scopus 로고
    • Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem
    • Falagas M.E., Siempos I.I., and Tsakoumis I. Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem. Scand J Infect Dis 38 (2006) 807-810
    • (2006) Scand J Infect Dis , vol.38 , pp. 807-810
    • Falagas, M.E.1    Siempos, I.I.2    Tsakoumis, I.3
  • 32
    • 0026447603 scopus 로고
    • Continuous infusion of beta-lactam antibiotics
    • Craig W.A., and Ebert S.C. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 36 (1992) 2577-2583
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 2577-2583
    • Craig, W.A.1    Ebert, S.C.2
  • 33
    • 0018664845 scopus 로고
    • A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients
    • Bodey G.P., Ketchel S.J., and Rodriguez V. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med 67 (1979) 608-616
    • (1979) Am J Med , vol.67 , pp. 608-616
    • Bodey, G.P.1    Ketchel, S.J.2    Rodriguez, V.3
  • 34
    • 0035916299 scopus 로고    scopus 로고
    • Antibiotic resistance in the intensive care unit
    • Kollef M.H., and Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med 134 4 (2001) 298-314
    • (2001) Ann Intern Med , vol.134 , Issue.4 , pp. 298-314
    • Kollef, M.H.1    Fraser, V.J.2
  • 35
    • 4043112107 scopus 로고    scopus 로고
    • Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management
    • Kaye K.S., Engemann J.J., Fraimow H.S., et al. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 18 3 (2004) 467-511
    • (2004) Infect Dis Clin North Am , vol.18 , Issue.3 , pp. 467-511
    • Kaye, K.S.1    Engemann, J.J.2    Fraimow, H.S.3
  • 37
    • 0021963387 scopus 로고
    • Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications
    • Sanders C.C., and Sanders Jr. W.E. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications. J Infect Dis 151 3 (1985) 399-406
    • (1985) J Infect Dis , vol.151 , Issue.3 , pp. 399-406
    • Sanders, C.C.1    Sanders Jr., W.E.2
  • 38
    • 33751014305 scopus 로고    scopus 로고
    • Clinical approach to antibiotic failure
    • Schlossberg D. Clinical approach to antibiotic failure. Med Clin North Am 90 6 (2006) 1265-1277
    • (2006) Med Clin North Am , vol.90 , Issue.6 , pp. 1265-1277
    • Schlossberg, D.1
  • 39
    • 0000688966 scopus 로고
    • Treatment of pneumoccic meningitis with penicillin compared with penicillin plus aureomycin. Studies including observations on an apparent antagonism between penicillin and aureomycin
    • Lepper M.H., and Dowling H.F. Treatment of pneumoccic meningitis with penicillin compared with penicillin plus aureomycin. Studies including observations on an apparent antagonism between penicillin and aureomycin. Arch Intern Med 88 (1951) 489-494
    • (1951) Arch Intern Med , vol.88 , pp. 489-494
    • Lepper, M.H.1    Dowling, H.F.2
  • 40
    • 0033658368 scopus 로고    scopus 로고
    • Antibiotic synergy and antagonism
    • Acar J.F. Antibiotic synergy and antagonism. Med Clin North Am 84 6 (2000) 1391-1406
    • (2000) Med Clin North Am , vol.84 , Issue.6 , pp. 1391-1406
    • Acar, J.F.1
  • 41
    • 0018092864 scopus 로고
    • Antibiotic antagonism and synergy
    • Matthews T. Antibiotic antagonism and synergy. Lancet 2 8085 (1978) 376-377
    • (1978) Lancet , vol.2 , Issue.8085 , pp. 376-377
    • Matthews, T.1
  • 42
    • 0027251106 scopus 로고
    • Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents
    • Neu H.C. Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents. Drugs 45 Suppl 3 (1993) 54-58
    • (1993) Drugs , vol.45 , Issue.SUPPL. 3 , pp. 54-58
    • Neu, H.C.1
  • 43
    • 70350580290 scopus 로고    scopus 로고
    • Initiation of inappropriate antimicrobial therapy results in a 5-fold reduction of survival in human septic shock
    • in press
    • Kumar A., Ellis P., Arabi Y., et al. Initiation of inappropriate antimicrobial therapy results in a 5-fold reduction of survival in human septic shock. Chest (2009) in press
    • (2009) Chest
    • Kumar, A.1    Ellis, P.2    Arabi, Y.3
  • 44
    • 0017615812 scopus 로고
    • Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations
    • Young L.S., Martin W.J., Meyer R.D., et al. Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med 86 (1977) 456-471
    • (1977) Ann Intern Med , vol.86 , pp. 456-471
    • Young, L.S.1    Martin, W.J.2    Meyer, R.D.3
  • 45
    • 0029583905 scopus 로고
    • Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
    • Romero-Vivas J., Rubio M., Fernandez C., et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 (1995) 1417-1423
    • (1995) Clin Infect Dis , vol.21 , pp. 1417-1423
    • Romero-Vivas, J.1    Rubio, M.2    Fernandez, C.3
  • 46
    • 0028806984 scopus 로고
    • Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study
    • Nguyen M.H., Peacock Jr. J.E., Tanner D.C., et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155 (1995) 2429-2435
    • (1995) Arch Intern Med , vol.155 , pp. 2429-2435
    • Nguyen, M.H.1    Peacock Jr., J.E.2    Tanner, D.C.3
  • 47
    • 0035797914 scopus 로고    scopus 로고
    • Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study
    • Vergis E.N., Hayden M.K., Chow J.W., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 135 (2001) 484-492
    • (2001) Ann Intern Med , vol.135 , pp. 484-492
    • Vergis, E.N.1    Hayden, M.K.2    Chow, J.W.3
  • 48
    • 34548138992 scopus 로고    scopus 로고
    • Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
    • Parkins M.D., Sabuda D.M., Elsayed S., et al. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60 (2007) 613-618
    • (2007) J Antimicrob Chemother , vol.60 , pp. 613-618
    • Parkins, M.D.1    Sabuda, D.M.2    Elsayed, S.3
  • 49
    • 0032765996 scopus 로고    scopus 로고
    • Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
    • [comment]
    • Byl B., Clevenbergh P., Jacobs F., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. [comment]. Clin Infect Dis 29 (1999) 60-66
    • (1999) Clin Infect Dis , vol.29 , pp. 60-66
    • Byl, B.1    Clevenbergh, P.2    Jacobs, F.3
  • 50
    • 43049150444 scopus 로고    scopus 로고
    • Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit
    • Raineri E., Pan A., Mondello P., et al. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 36 4 (2008) 283-290
    • (2008) Am J Infect Control , vol.36 , Issue.4 , pp. 283-290
    • Raineri, E.1    Pan, A.2    Mondello, P.3
  • 51
    • 0032401701 scopus 로고    scopus 로고
    • Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing
    • Aronin S.I., Peduzzi P., and Quagliarello V.J. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129 (1998) 862-869
    • (1998) Ann Intern Med , vol.129 , pp. 862-869
    • Aronin, S.I.1    Peduzzi, P.2    Quagliarello, V.J.3
  • 52
    • 0035213049 scopus 로고    scopus 로고
    • Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center
    • Miner J.R., Heegaard W., Mapes A., et al. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 21 (2001) 387-392
    • (2001) J Emerg Med , vol.21 , pp. 387-392
    • Miner, J.R.1    Heegaard, W.2    Mapes, A.3
  • 53
    • 17044414100 scopus 로고    scopus 로고
    • Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis
    • Proulx N., Frechette D., Toye B., et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 98 (2005) 291-298
    • (2005) QJM , vol.98 , pp. 291-298
    • Proulx, N.1    Frechette, D.2    Toye, B.3
  • 54
    • 1642286527 scopus 로고    scopus 로고
    • Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia
    • Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 (2004) 637-644
    • (2004) Arch Intern Med , vol.164 , pp. 637-644
    • Houck, P.M.1    Bratzler, D.W.2    Nsa, W.3
  • 55
    • 0032437068 scopus 로고    scopus 로고
    • Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections
    • Natsch S., Kullberg B.J., Van der Meer J.W., et al. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 17 10 (1998) 681-684
    • (1998) Eur J Clin Microbiol Infect Dis , vol.17 , Issue.10 , pp. 681-684
    • Natsch, S.1    Kullberg, B.J.2    Van der Meer, J.W.3
  • 56
    • 0028832117 scopus 로고
    • Determination of plasma concentrations of amikacin in patients of an intensive care unit
    • Pimentel F.L., Abelha F., Trigo M.A., et al. Determination of plasma concentrations of amikacin in patients of an intensive care unit. J Chemother 7 (1995) 45-49
    • (1995) J Chemother , vol.7 , pp. 45-49
    • Pimentel, F.L.1    Abelha, F.2    Trigo, M.A.3
  • 57
    • 0026322390 scopus 로고
    • Effect of individualized pharmacokinetic dosing on patient outcome
    • Whipple J.K., Ausman R.K., Franson T., et al. Effect of individualized pharmacokinetic dosing on patient outcome. Crit Care Med 19 (1991) 1480-1485
    • (1991) Crit Care Med , vol.19 , pp. 1480-1485
    • Whipple, J.K.1    Ausman, R.K.2    Franson, T.3
  • 58
    • 0035112931 scopus 로고    scopus 로고
    • Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock
    • Joukhadar C., Frossard M., Mayer B.X., et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29 (2001) 385-391
    • (2001) Crit Care Med , vol.29 , pp. 385-391
    • Joukhadar, C.1    Frossard, M.2    Mayer, B.X.3
  • 59
    • 0023754003 scopus 로고
    • Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods
    • Franson T.R., Quebbeman E.J., Whipple J., et al. Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods. Crit Care Med 16 (1988) 840-843
    • (1988) Crit Care Med , vol.16 , pp. 840-843
    • Franson, T.R.1    Quebbeman, E.J.2    Whipple, J.3
  • 60
    • 0036095347 scopus 로고    scopus 로고
    • Tissue distribution of imipenem in critically ill patients
    • Tegeder I., Schmidtko A., Brautigam L., et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 71 (2002) 325-333
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 325-333
    • Tegeder, I.1    Schmidtko, A.2    Brautigam, L.3
  • 61
    • 0021364813 scopus 로고
    • The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia
    • Moore R.D., Smith C.R., and Lietman P.S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 149 (1984) 443-448
    • (1984) J Infect Dis , vol.149 , pp. 443-448
    • Moore, R.D.1    Smith, C.R.2    Lietman, P.S.3
  • 62
    • 0021221208 scopus 로고
    • Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia
    • Moore R.D., Smith C.R., and Lietman P.S. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77 (1984) 657-662
    • (1984) Am J Med , vol.77 , pp. 657-662
    • Moore, R.D.1    Smith, C.R.2    Lietman, P.S.3
  • 63
    • 0027161344 scopus 로고
    • Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
    • Forrest A., Nix D.E., Ballow C.H., et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37 (1993) 1073-1081
    • (1993) Antimicrob Agents Chemother , vol.37 , pp. 1073-1081
    • Forrest, A.1    Nix, D.E.2    Ballow, C.H.3
  • 64
    • 0032515386 scopus 로고    scopus 로고
    • Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials
    • Preston S.L., Drusano G.L., Berman A.L., et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279 (1998) 125-129
    • (1998) JAMA , vol.279 , pp. 125-129
    • Preston, S.L.1    Drusano, G.L.2    Berman, A.L.3
  • 65
    • 2442549489 scopus 로고    scopus 로고
    • Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
    • Drusano G.L., Preston S.L., Fowler C., et al. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189 (2004) 1590-1597
    • (2004) J Infect Dis , vol.189 , pp. 1590-1597
    • Drusano, G.L.1    Preston, S.L.2    Fowler, C.3
  • 66
    • 0023119430 scopus 로고
    • Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration
    • Moore R.D., Lietman P.S., and Smith C.R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155 (1987) 93-99
    • (1987) J Infect Dis , vol.155 , pp. 93-99
    • Moore, R.D.1    Lietman, P.S.2    Smith, C.R.3
  • 67
    • 0032979927 scopus 로고    scopus 로고
    • Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria
    • Kashuba A.D., Nafziger A.N., Drusano G.L., et al. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrobial Agents & Chemotherapy 43 (1999) 623-629
    • (1999) Antimicrobial Agents & Chemotherapy , vol.43 , pp. 623-629
    • Kashuba, A.D.1    Nafziger, A.N.2    Drusano, G.L.3
  • 68
    • 0021708980 scopus 로고
    • Role for dual individualization with cefmenoxime
    • Schentag J.J., Smith I.L., Swanson D.J., et al. Role for dual individualization with cefmenoxime. Am J Med 77 (1984) 43-50
    • (1984) Am J Med , vol.77 , pp. 43-50
    • Schentag, J.J.1    Smith, I.L.2    Swanson, D.J.3
  • 69
    • 0028785941 scopus 로고
    • Once-daily versus multiple-daily dosing of aminoglycosides
    • Craig W.A. Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother 7 Suppl 2 (1995) 47-52
    • (1995) J Chemother , vol.7 , Issue.SUPPL. 2 , pp. 47-52
    • Craig, W.A.1
  • 70
    • 0031807608 scopus 로고    scopus 로고
    • Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms
    • Kashuba A.D., Bertino Jr. J.S., and Nafziger A.N. Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms. Antimicrobial Agents & Chemotherapy 42 (1998) 1842-1844
    • (1998) Antimicrobial Agents & Chemotherapy , vol.42 , pp. 1842-1844
    • Kashuba, A.D.1    Bertino Jr., J.S.2    Nafziger, A.N.3
  • 71
    • 0023920993 scopus 로고
    • Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime
    • Daenen S., and Vries-Hospers H. Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime. Lancet 1 (1988) 937
    • (1988) Lancet , vol.1 , pp. 937
    • Daenen, S.1    Vries-Hospers, H.2
  • 72
    • 0036776275 scopus 로고    scopus 로고
    • Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation
    • Egerer G., Goldschmidt H., Hensel M., et al. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation. Bone Marrow Transplant 30 (2002) 427-431
    • (2002) Bone Marrow Transplant , vol.30 , pp. 427-431
    • Egerer, G.1    Goldschmidt, H.2    Hensel, M.3
  • 73
    • 0030067765 scopus 로고    scopus 로고
    • Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections
    • Benko A.S., Cappelletty D.M., Kruse J.A., et al. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrobial Agents & Chemotherapy 40 (1996) 691-695
    • (1996) Antimicrobial Agents & Chemotherapy , vol.40 , pp. 691-695
    • Benko, A.S.1    Cappelletty, D.M.2    Kruse, J.A.3
  • 74
    • 0345130000 scopus 로고    scopus 로고
    • Continuous infusion versus intermittent administration of meropenem in critically ill patients
    • Thalhammer F., Traunmuller F., El M., et al. Continuous infusion versus intermittent administration of meropenem in critically ill patients. J Antimicrob Chemother 43 (1999) 523-527
    • (1999) J Antimicrob Chemother , vol.43 , pp. 523-527
    • Thalhammer, F.1    Traunmuller, F.2    El, M.3
  • 75
    • 0035141347 scopus 로고    scopus 로고
    • Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock
    • Sfeir T., Saha D.C., Astiz M., et al. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29 (2001) 129-133
    • (2001) Crit Care Med , vol.29 , pp. 129-133
    • Sfeir, T.1    Saha, D.C.2    Astiz, M.3
  • 76
    • 0031943481 scopus 로고    scopus 로고
    • Monocyte function before and after surgical trauma
    • Haupt W., Riese J., Mehler C., et al. Monocyte function before and after surgical trauma. Dig Surg 15 (1998) 102-104
    • (1998) Dig Surg , vol.15 , pp. 102-104
    • Haupt, W.1    Riese, J.2    Mehler, C.3
  • 77
    • 0030036614 scopus 로고    scopus 로고
    • Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes
    • Brandtzaeg P., Osnes L., Ovstebo R., et al. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184 (1996) 51-60
    • (1996) J Exp Med , vol.184 , pp. 51-60
    • Brandtzaeg, P.1    Osnes, L.2    Ovstebo, R.3
  • 78
    • 0031755096 scopus 로고    scopus 로고
    • Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo
    • Williams M.A., Withington S., Newland A.C., et al. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis 178 (1998) 1421-1433
    • (1998) J Infect Dis , vol.178 , pp. 1421-1433
    • Williams, M.A.1    Withington, S.2    Newland, A.C.3
  • 79
    • 0036256051 scopus 로고    scopus 로고
    • Failure of neutrophil chemotactic function in septic patients
    • Tavares-Murta B.M., Zaparoli M., Ferreira R.B., et al. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30 (2002) 1056-1061
    • (2002) Crit Care Med , vol.30 , pp. 1056-1061
    • Tavares-Murta, B.M.1    Zaparoli, M.2    Ferreira, R.B.3
  • 80
    • 0036392072 scopus 로고    scopus 로고
    • Phagocytosis by emigrated, intra-abdominal neutrophils is depressed during human secondary peritonitis
    • Holzer K., Konietzny P., Wilhelm K., et al. Phagocytosis by emigrated, intra-abdominal neutrophils is depressed during human secondary peritonitis. Eur Surg Res 34 (2002) 275-284
    • (2002) Eur Surg Res , vol.34 , pp. 275-284
    • Holzer, K.1    Konietzny, P.2    Wilhelm, K.3
  • 81
    • 0033929552 scopus 로고    scopus 로고
    • Role of nitric oxide in the failure of neutrophil migration in sepsis
    • Benjamim C.F., Ferreira S.H., and Cunha F.Q. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 182 (2000) 214-223
    • (2000) J Infect Dis , vol.182 , pp. 214-223
    • Benjamim, C.F.1    Ferreira, S.H.2    Cunha, F.Q.3
  • 82
    • 0025865688 scopus 로고
    • Monotherapy versus combination antimicrobial therapy: a review
    • Barriere S.L. Monotherapy versus combination antimicrobial therapy: a review. Pharmacotherapy 11 (1991) 64S-71S
    • (1991) Pharmacotherapy , vol.11
    • Barriere, S.L.1
  • 83
    • 0037087226 scopus 로고    scopus 로고
    • 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
    • Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
    • (2002) Clin Infect Dis , vol.34 , pp. 730-751
    • Hughes, W.T.1    Armstrong, D.2    Bodey, G.P.3
  • 85
    • 0024387119 scopus 로고
    • Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients
    • Hilf M., Yu V.L., Sharp J., et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87 (1989) 540-546
    • (1989) Am J Med , vol.87 , pp. 540-546
    • Hilf, M.1    Yu, V.L.2    Sharp, J.3
  • 86
    • 0025938759 scopus 로고
    • Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy
    • Chow J.W., Fine M.J., Shlaes D.M., et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115 (1991) 585-590
    • (1991) Ann Intern Med , vol.115 , pp. 585-590
    • Chow, J.W.1    Fine, M.J.2    Shlaes, D.M.3
  • 87
    • 0026473059 scopus 로고
    • Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy
    • Korvick J.A., Bryan C.S., Farber B., et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrobial Agents & Chemotherapy 36 (1992) 2639-2644
    • (1992) Antimicrobial Agents & Chemotherapy , vol.36 , pp. 2639-2644
    • Korvick, J.A.1    Bryan, C.S.2    Farber, B.3
  • 88
    • 0017927868 scopus 로고
    • Antimicrobial synergism in the therapy of gram-negative rod bacteremia
    • Anderson E.T., Young L.S., and Hewitt W.L. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy 24 (1978) 45-54
    • (1978) Chemotherapy , vol.24 , pp. 45-54
    • Anderson, E.T.1    Young, L.S.2    Hewitt, W.L.3
  • 89
    • 4544244010 scopus 로고    scopus 로고
    • Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
    • Baddour L.M., Yu V.L., Klugman K.P., et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170 4 (2004) 440-444
    • (2004) Am J Respir Crit Care Med , vol.170 , Issue.4 , pp. 440-444
    • Baddour, L.M.1    Yu, V.L.2    Klugman, K.P.3
  • 90
    • 0034890569 scopus 로고    scopus 로고
    • Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia
    • Waterer G.W., Somes G.W., and Wunderink R.G. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161 (2001) 1837-1842
    • (2001) Arch Intern Med , vol.161 , pp. 1837-1842
    • Waterer, G.W.1    Somes, G.W.2    Wunderink, R.G.3
  • 91
    • 0037442372 scopus 로고    scopus 로고
    • Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
    • Martinez J.A., Horcajada J.P., Almela M., et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36 (2003) 389-395
    • (2003) Clin Infect Dis , vol.36 , pp. 389-395
    • Martinez, J.A.1    Horcajada, J.P.2    Almela, M.3
  • 92
    • 34249304464 scopus 로고    scopus 로고
    • Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
    • Rodriguez A., Mendia A., Sirvent J.M., et al. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 35 (2007) 1493-1498
    • (2007) Crit Care Med , vol.35 , pp. 1493-1498
    • Rodriguez, A.1    Mendia, A.2    Sirvent, J.M.3
  • 93
    • 0029788247 scopus 로고    scopus 로고
    • International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee
    • Sprung C.L., Finch R.G., Thijs L.G., et al. International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med 24 (1996) 1441-1447
    • (1996) Crit Care Med , vol.24 , pp. 1441-1447
    • Sprung, C.L.1    Finch, R.G.2    Thijs, L.G.3
  • 94
    • 0023472263 scopus 로고
    • Improved results from a standardized approach in treating patients with necrotizing fasciitis
    • Sudarsky L.A., Laschinger J.C., Coppa G.F., et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 206 (1987) 661-665
    • (1987) Ann Surg , vol.206 , pp. 661-665
    • Sudarsky, L.A.1    Laschinger, J.C.2    Coppa, G.F.3
  • 95
    • 0029820595 scopus 로고    scopus 로고
    • Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival
    • Moss R.L., Musemeche C.A., and Kosloske A.M. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31 (1996) 1142-1146
    • (1996) J Pediatr Surg , vol.31 , pp. 1142-1146
    • Moss, R.L.1    Musemeche, C.A.2    Kosloske, A.M.3
  • 96
    • 70350578312 scopus 로고    scopus 로고
    • Outcome of septic shock correlates with duration of hypotension prior to source control implementation
    • Kumar A., Wood K., Gurka D., et al. Outcome of septic shock correlates with duration of hypotension prior to source control implementation. ICAAC Proceedings 350 (2004) K-1222
    • (2004) ICAAC Proceedings , vol.350
    • Kumar, A.1    Wood, K.2    Gurka, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.